These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11336456)

  • 1. Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim.
    Friedman LC; Webb JA; Richards CS; Lynch GR; Kaplan AL; Brunicardi FC; Plon SE
    Genet Med; 1999; 1(3):74-9. PubMed ID: 11336456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychological impact of a negative BRCA1 test: a wolf in sheep's clothing?
    Wiesner GL
    Genet Med; 1999; 1(3):69-70. PubMed ID: 11336454
    [No Abstract]   [Full Text] [Related]  

  • 3. Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: a community-based study.
    Plon SE; Peterson LE; Friedman LC; Richards CS
    Genet Med; 2000; 2(6):307-11. PubMed ID: 11339650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
    Beran TM; Stanton AL; Kwan L; Seldon J; Bower JE; Vodermaier A; Ganz PA
    Ann Behav Med; 2008 Oct; 36(2):107-16. PubMed ID: 18787910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
    O'Neill SC; Rini C; Goldsmith RE; Valdimarsdottir H; Cohen LH; Schwartz MD
    Psychooncology; 2009 Oct; 18(10):1088-96. PubMed ID: 19214961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
    J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
    Schwartz MD; Peshkin BN; Hughes C; Main D; Isaacs C; Lerman C
    J Clin Oncol; 2002 Jan; 20(2):514-20. PubMed ID: 11786581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for 185delAG in the Ashkenazim.
    Richards CS; Ward PA; Roa BB; Friedman LC; Boyd AA; Kuenzli G; Dunn JK; Plon SE
    Am J Hum Genet; 1997 May; 60(5):1085-98. PubMed ID: 9150156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological responses to BRCA1 mutation testing: preliminary findings.
    Croyle RT; Smith KR; Botkin JR; Baty B; Nash J
    Health Psychol; 1997 Jan; 16(1):63-72. PubMed ID: 9028816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
    Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
    Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit finding in response to BRCA1/2 testing.
    Low CA; Bower JE; Kwan L; Seldon J
    Ann Behav Med; 2008 Feb; 35(1):61-9. PubMed ID: 18347905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing.
    Smith KR; West JA; Croyle RT; Botkin JR
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):385-92. PubMed ID: 10207644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy.
    Hanoch Y; Miron-Shatz T; Rolison JJ; Ozanne E
    Psychooncology; 2014 Oct; 23(10):1142-8. PubMed ID: 24733657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
    Dorval M; Patenaude AF; Schneider KA; Kieffer SA; DiGianni L; Kalkbrenner KJ; Bromberg JI; Basili LA; Calzone K; Stopfer J; Weber BL; Garber JE
    J Clin Oncol; 2000 May; 18(10):2135-42. PubMed ID: 10811679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.
    Bar-Sade RB; Kruglikova A; Modan B; Gak E; Hirsh-Yechezkel G; Theodor L; Novikov I; Gershoni-Baruch R; Risel S; Papa MZ; Ben-Baruch G; Friedman E
    Hum Mol Genet; 1998 May; 7(5):801-5. PubMed ID: 9536083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of patients at high risk of psychological distress after BRCA1 genetic testing.
    Ertmański S; Metcalfe K; Trempała J; Głowacka MD; Lubiński J; Narod SA; Gronwald J
    Genet Test Mol Biomarkers; 2009 Jun; 13(3):325-30. PubMed ID: 19405874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.
    Phillips KA; Warner E; Meschino WS; Hunter J; Abdolell M; Glendon G; Andrulis IL; Goodwin PJ
    Clin Genet; 2000 May; 57(5):376-83. PubMed ID: 10852372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
    Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
    J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].
    Leblond D; Brédart A; Dolbeault S; De Pauw A; Stoppa Lyonnet D; Flahault C; Sultan S
    Bull Cancer; 2011 Feb; 98(2):184-98. PubMed ID: 21382771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
    Shattuck-Eidens D; Oliphant A; McClure M; McBride C; Gupte J; Rubano T; Pruss D; Tavtigian SV; Teng DH; Adey N; Staebell M; Gumpper K; Lundstrom R; Hulick M; Kelly M; Holmen J; Lingenfelter B; Manley S; Fujimura F; Luce M; Ward B; Cannon-Albright L; Steele L; Offit K; Thomas A
    JAMA; 1997 Oct; 278(15):1242-50. PubMed ID: 9333265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.